Effects of immunomodulatory and organism-associated molecules on the permeability of an In Vitro blood-brain barrier model to amphotericin B and fluconazole

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 3, 2010, Pages 1305-1310

  Pyrgos, Vasilios ^a   Mickiene, Diane ^a   Sein, Tin ^a   Cotton, Margaret ^a   Fransesconi, Andrea ^a   Mizrahi, Isaac ^b   Donoghue, Martha ^a,c   Bundrant, Nikkida ^a   Kim, Su Young ^a   Hardwick, Matthew ^b,d   Shoham, Shmuel ^b,d   Walsh, Thomas J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CYCLOSPORIN; DEXAMETHASONE; FLUCONAZOLE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; PROTEIN ZO1; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG PENETRATION; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; EXPERIMENTAL STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOFLUORESCENCE TEST; IMMUNOMODULATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; TIGHT JUNCTION;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CATTLE; CELL LINE, TUMOR; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; FLUCONAZOLE; IMMUNOLOGIC FACTORS; RATS; TIGHT JUNCTIONS;

EID: 77149135234     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01263-09     Document Type: Article

References (20)

1. Aloudah, N., M. Radwan, N. Al Omar, and S. Jacobs. 2005. HPLC assay of fluconazole and its application to patients with early septic shock. J. Liquid Chromatogr. Related Technol. 28:571-580.
2. Arndt, C. A., T. J. Walsh, C. L. McCully, F. M. Balis, P. A. Pizzo, and D. G. Poplack. 1988. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J. Infect. Dis. 157:178-180.
3. Brammer, K. W., P. R. Farrow, and J. K. Faulkner. 1990. Pharmacokinetics and tissue penetration of fluconazole in humans. Rev. Infect. Dis. 12(Suppl. 3):S318-S326.
4. Chin, T., I. W. Fong, and A. Vandenbroucke. 1990. Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis. Pharmacotherapy 10:305-307.
5. Cucullo, L., K. Hallene, G. Dini, R. Dal Toso, and D. Janigro. 2004. Glycerophosphoinositol and dexamethasone improve transendothelial electrical resistance in an in vitro study of the blood-brain barrier. Brain Res. 997: 147-151.
6. Delbro, D., A. Westerlund, U. Bjorklund, and E. Hansson. 2009. In inflammatory reactive astrocytes cultured with brain endothelial cells nicotine-evoked Ca(2+) transients are attenuated due to interleukin-1beta release and rearrangement of actin filaments. Neuroscience 159:770-779.
7. Dotis, J., E. Iosifidis, and E. Roilides. 2007. Central nervous system aspergillosis in children: a systematic review of reported cases. Int. J. Infect. Dis. 11:381-393.
8. Fox, J. L. 2006. In children with bacterial meningitis, does the addition of dexamethasone to an antibiotic treatment regimen result in a better clinical outcome than the antibiotic regimen alone? Part A. Evidence-based answer and summary. Paediatr. Child Health 11:33-34.
9. Gaillard, P. J., and A. G. de Boer. 2000. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur. J. Pharm. Sci. 12:95-102.
10. Groll, A. H., N. Giri, V. Petraitis, R. Petraitiene, M. Candelario, J. S. Bacher, S. C. Piscitelli, and T. J. Walsh. 2000. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J. Infect. Dis. 182:274-282.
11. Hope, W. W., M. J. Kruhlak, C. A. Lyman, R. Petraitiene, V. Petraitis, A. Francesconi, M. Kasai, D. Mickiene, T. Sein, J. Peter, A. M. Kelaher, J. E. Hughes, M. P. Cotton, C. J. Cotten, J. Bacher, S. Tripathi, L. Bermudez, T. K. Maugel, P. M. Zerfas, J. R. Wingard, G. L. Drusano, and T. J. Walsh. 2007. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J. Infect. Dis. 195:455-466.
12. Keshavarzian, A., A. Banan, A. Farhadi, S. Komanduri, E. Mutlu, Y. Zhang, and J. Z. Fields. 2003. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52:720-728.
13. Madu, A., C. Cioffe, U. Mian, M. Burroughs, E. Tuomanen, M. Mayers, E. Schwartz, and M. Miller. 1994. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid. Antimicrob. Agents Chemother. 38:2111-2115.
14. Mian, U. K., M. Mayers, Y. Garg, Q. F. Liu, G. Newcomer, C. Madu, W. Liu, A. Louie, and M. H. Miller. 1998. Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state. J. Ocul. Pharmacol. Ther. 14: 459-471.
15. Pyrgos, V., V. Petraitis, R. Petraitiene, D. Mickiene, M. Cotton, L. Greene, T. Aghamolla, J. Valdez, M. Mocanu, N. Brundant, M. Donoghue, D. Benjamin, M. Hardwick, S. Shoham, and T. Walsh. 2009. Permeability of the blood brain barrier to amphotericin B is focally increased in experimental hematogenous candida meningoencephalitis, abstr. 2227. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
16. Roden, M. M., T. E. Zaoutis, W. L. Buchanan, T. A. Knudsen, T. A. Sarkisova, R. L. Schaufele, M. Sein, T. Sein, C. C. Chiou, J. H. Chu, D. P. Kontoyiannis, and T. J. Walsh. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653.
17. Rubin, L. L., D. E. Hall, S. Porter, K. Barbu, C. Cannon, H. C. Horner, M. Janatpour, C. W. Liaw, K. Manning, J. Morales, et al. 1991. A cell culture model of the blood-brain barrier. J. Cell Biol. 115:1725-1735.
18. Saag, M. S., R. J. Graybill, R. A. Larsen, P. G. Pappas, J. R. Perfect, W. G. Powderly, J. D. Sobel, and W. E. Dismukes. 2000. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin. Infect. Dis. 30:710-718.
19. Thaler, F., B. Bernard, M. Tod, C. P. Jedynak, O. Petitjean, P. Derome, and P. Loirat. 1995. Fluconazole penetration in cerebral parenchyma in humans at steady state. Antimicrob. Agents Chemother. 39:1154-1156.
20. Walsh, T. J., J. W. Hiemenz, N. L. Seibel, J. R. Perfect, G. Horwith, L. Lee, J. L. Silber, M. J. DiNubile, A. Reboli, E. Bow, J. Lister, and E. J. Anaissie. 1998. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin. Infect. Dis. 26:1383-1396.